Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Bull Exp Biol Med ; 172(3): 385-389, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35001303

RESUMEN

We conducted a comparative study of the calculated indices of insulin resistance HOMA-R, Caro, FGIR, and QUICKI in 29 healthy volunteers (mean age 26.21±0.93 years) with normal body mass index (23.34±0.55 kg/m2). Among the used methods for insulin resistance assessment, QUICKI is the only method that has characteristics required for the diagnostic criterium: low variability coefficient, 100% reproducibility, and minimum coefficient of variation.


Asunto(s)
Resistencia a la Insulina , Adulto , Glucemia , Humanos , Insulina , Reproducibilidad de los Resultados
2.
Bull Exp Biol Med ; 166(1): 19-21, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30450517

RESUMEN

A cross-sectional study performed on a continuous sample of 32 patients (mean age 46.36±3.31 years) with gastroesophageal reflux disease and excess body weight showed that the disturbance of sympathetic/parasympathetic relationships, disruption of segmental and compensatory increase in the suprasegmental mechanisms of autonomic regulation determines the course of gastroesophageal reflux disease in these patients.


Asunto(s)
Sistema Nervioso Autónomo/patología , Sistema Nervioso Autónomo/fisiopatología , Reflujo Gastroesofágico/patología , Reflujo Gastroesofágico/fisiopatología , Adulto , Peso Corporal/fisiología , Estudios Transversales , Femenino , Humanos , Masculino
3.
Artículo en Ruso | MEDLINE | ID: mdl-30193038

RESUMEN

The article presents the results of investigation of features of dynamics of main demographic indices characterizing epidemic condition with tuberculosis in Samara during last decade. The gender age, social and clinical structures of patients spotted for the first time.


Asunto(s)
Tuberculosis , Humanos , Federación de Rusia/epidemiología , Tuberculosis/epidemiología
4.
Bull Exp Biol Med ; 165(2): 213-215, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29923009

RESUMEN

А cross-sectional study was performed on a continuous sample of patients (N=52) with the gastroesophageal reflux disease. Specific features of this disease in patients with overweight were revealed. Regurgitation predominated in the structure of complaints. Fibrogastroduodenoscopy revealed endoscopically negative form of the diseases in 38% of cases. According to 24-h pH monitoring results, alkaline reflux pH>7 took more than 25% time in supine position at high DeMeester score, which limits the usage of aggressive acid-lowering therapy.


Asunto(s)
Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/epidemiología , Sobrepeso/complicaciones , Sobrepeso/epidemiología , Adulto , Índice de Masa Corporal , Estudios Transversales , Endoscopía Gastrointestinal , Esófago/metabolismo , Esófago/patología , Femenino , Reflujo Gastroesofágico/diagnóstico , Reflujo Gastroesofágico/terapia , Humanos , Concentración de Iones de Hidrógeno , Masculino , Persona de Mediana Edad , Sobrepeso/diagnóstico , Sobrepeso/terapia , Medicina de Precisión , Índice de Severidad de la Enfermedad , Adulto Joven
5.
Bull Exp Biol Med ; 165(1): 18-21, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29797128

RESUMEN

JAK/STAT signaling pathway was examined during functional stimulation of mesenchymal progenitor cells with fibroblast growth factor. The differences were observed in the realizations of the proliferation-differentiation potential of CFU-fibroblasts under blockade of JAKs or during selective inactivation of STAT3. The study revealed stimulating influences of JAKs and STAT3 on mitotic activity of progenitor cells and individual roles of these proteins in the control of their maturation. Blockade of JAKs diminished the level of fibroblast colony formation and the score of actively proliferating CFU-fibroblasts at the background increase of the differentiation rate of progenitor cells. In contrast, STAT3 inhibitor resulted in a coordinated decrease of all examined parameters.


Asunto(s)
Factores de Crecimiento de Fibroblastos/farmacología , Quinasas Janus/metabolismo , Células Madre Mesenquimatosas/efectos de los fármacos , Células Madre Mesenquimatosas/metabolismo , Factor de Transcripción STAT3/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Ratones Endogámicos C57BL , Fosforilación/efectos de los fármacos , Medicina Regenerativa , Transducción de Señal/efectos de los fármacos
6.
Bull Exp Biol Med ; 164(3): 316-319, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29308566

RESUMEN

The role of JAK/STAT3-mediated signaling pathway in the realization of the growth potential of mesenchymal precursor cells was examined in vitro. The stimulating role of JAKs and STAT3 towards proliferating activity of progenitor cells and their different role in the regulation of differentiation of the progenitor elements were demonstrated. Inhibitors of JAKs and STAT3 reduced the yield of fibroblast CFU and their mitotic activity. Blockade of JAKs accelerated and selective inactivation of STAT3 decelerated differentiation of progenitor cells.


Asunto(s)
Células de la Médula Ósea/metabolismo , Fibroblastos/metabolismo , Janus Quinasa 1/genética , Janus Quinasa 3/genética , Células Madre Mesenquimatosas/metabolismo , Factor de Transcripción STAT3/genética , Animales , Antraquinonas/farmacología , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Regulación de la Expresión Génica , Janus Quinasa 1/antagonistas & inhibidores , Janus Quinasa 1/metabolismo , Janus Quinasa 3/antagonistas & inhibidores , Janus Quinasa 3/metabolismo , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Nitrilos , Fosforilación , Cultivo Primario de Células , Pirazoles/farmacología , Pirimidinas , Factor de Transcripción STAT3/antagonistas & inhibidores , Factor de Transcripción STAT3/metabolismo , Transducción de Señal , Sulfonamidas/farmacología
7.
Bull Exp Biol Med ; 164(3): 304-307, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29313228
8.
Bull Exp Biol Med ; 164(1): 10-14, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29124537

RESUMEN

A cross-sectional study of universe sample of patients (N=135; mean age -49.7±0.8 years) with metabolic syndrome yielded the incidence of cardiac autonomic neuropathy of 37.5%. The pathogenetic peculiarities were revealed for the onset and development of this neuropathy. At the early stages, the progress of cardiac autonomic neuropathy closely correlated with elevation of blood glucose, while endothelial dysfunction progressing at the later period against the background of persistent hyperglycemia is viewed as an extra factor contributing to the development of this disease.


Asunto(s)
Síndrome Metabólico/patología , Enfermedades del Sistema Nervioso Periférico/patología , Adulto , Sistema Nervioso Autónomo/patología , Sistema Nervioso Autónomo/fisiopatología , Glucemia , Estudios Transversales , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/fisiopatología , Persona de Mediana Edad , Enfermedades del Sistema Nervioso Periférico/sangre , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Factores de Riesgo , Volumen Sistólico
9.
Bull Exp Biol Med ; 162(1): 38-41, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27878727

RESUMEN

In a 3-month study, 30 obese patients were assigned to lifestyle modification therapy, which is the major component of all modern strategies correcting the metabolic syndrome. The 3-month course of non-pharmacological therapy significantly diminished the major index evaluating the state of these patients, i.e., the risk of cardiovascular disasters. This therapy positively affected all the states associated with metabolic syndrome: arterial BP attained the targets in 53% patients together with normalization of their nocturnal arterial BP dipping status; the lipid panel and carbohydrate metabolic indices normalized in 46 and 44% patients, respectively; hepatic steatosis moderated in 56% patients; and the disturbances in hemostasis were annihilated in 67% patients.


Asunto(s)
Restricción Calórica/métodos , Enfermedades Cardiovasculares/dietoterapia , Hígado Graso/dietoterapia , Síndrome Metabólico/dietoterapia , Obesidad/dietoterapia , Conducta de Reducción del Riesgo , Adulto , Glucemia/metabolismo , Presión Sanguínea , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/fisiopatología , Enfermedades Cardiovasculares/prevención & control , HDL-Colesterol/sangre , LDL-Colesterol/sangre , VLDL-Colesterol/sangre , Ejercicio Físico , Hígado Graso/sangre , Hígado Graso/fisiopatología , Humanos , Estilo de Vida , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/fisiopatología , Persona de Mediana Edad , Obesidad/sangre , Obesidad/fisiopatología , Estudios Prospectivos , Triglicéridos/sangre
10.
Bull Exp Biol Med ; 161(2): 237-40, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27383176

RESUMEN

ANS support of the cardiac work was assessed with analysis of heart rate variability in representative samples of patients with arterial hypertension and metabolic disturbances manifested by overweight, classes I-II obesity, compromised glucose tolerance, and type II diabetes. Initially enhanced sympathetic effects on the heart rate demonstrated no further increase during the orthostatic test in contrast to suprasegmentary influences enhanced by this test. The pronouncedness of revealed peculiarities in ANS drive to the heart correlated with metabolic disturbances, and these peculiarities attained maximum in patients with type II diabetes.


Asunto(s)
Sistema Nervioso Autónomo/fisiopatología , Diabetes Mellitus Tipo 2/fisiopatología , Hipertensión/fisiopatología , Obesidad/fisiopatología , Estudios Transversales , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Contracción Miocárdica
11.
Bull Exp Biol Med ; 159(2): 205-8, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26085352

RESUMEN

Comparative analysis of the effectiveness of global tests for evaluation of the blood coagulation systems demonstrated the possibility of obtaining express data on hemostasis stages I-II and III when working with native substrate (whole blood). Changes in viscous characteristics of the whole blood recorded ex vivo during hemocoagulation allowed us to propose the concept of permanency of fibrinogenesis as the obligatory in vivo process determining the hemostatic potential, an integral characteristic of the hemocoagulation cycle providing sufficient blood fluidity and limiting extravasation of blood components under conditions of permeability disturbances and damage to the vascular wall.


Asunto(s)
Pruebas de Coagulación Sanguínea/métodos , Coagulación Sanguínea/fisiología , Viscosidad Sanguínea/fisiología , Agregación Eritrocitaria/fisiología , Fibrinógeno/metabolismo , Hemostasis/fisiología , Adolescente , Adulto , Humanos , Tromboelastografía/métodos
12.
Voen Med Zh ; 333(4): 55-9, 2012 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-22712251

RESUMEN

The study presents retrospective analysis of navy soldiers' cardiovascular diseases, which most often cause the growth in labor force, loss rates and navy soldiers' dismissal and mortality rates, and, therefore, are one of the most pressing problems of the military medical services. Comparative assessment conducted between emergence and pervasiveness of these diseases in navy with those of land-based soldiers. Analysis of correlation between morbidity rates and length of service in navy is also included.


Asunto(s)
Enfermedades Cardiovasculares/mortalidad , Personal Militar , Adolescente , Adulto , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Federación de Rusia
13.
Bull Exp Biol Med ; 151(4): 400-4, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22448351

RESUMEN

A 6-month clinical study with active therapeutic intervention was carried out to evaluate the efficacy of moxonidine for the correction of arterial hypertension in 30 patients with metabolic syndrome. Along with the metabolic neutrality for the lipid and purine metabolism, the drug demonstrated a distinct antihypertensive effect, which against the background of pronounced sympatholytic action after 3 months of therapy tends to disappear, which can be prevented by dosage correction. It was shown that the efficacy of moxonidine in reducing insulin resistance in patients with metabolic syndrome directly depends on the severity of hypersympathicotonia manifesting in heart rate over 80 bpm at rest.


Asunto(s)
Antihipertensivos/uso terapéutico , Hipertensión/tratamiento farmacológico , Imidazoles/uso terapéutico , Síndrome Metabólico/complicaciones , Hormona Adrenocorticotrópica/sangre , Femenino , Humanos , Hidrocortisona/sangre , Hipertensión/etiología , Resistencia a la Insulina , Masculino , Persona de Mediana Edad
14.
Bull Exp Biol Med ; 151(2): 183-5, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22238745

RESUMEN

We examined 38 patients (mean age 55.92 ± 1.56 years) with a 3-5-year history of arterial hypertension. The study showed that hypertension is accompanied by endothelial dysfunction and one of its forming factors is activation of the inflammatory response. Highly sensitive diagnostic tests can verify initiation of inflammation in preclinical manifestations. The use of nonsteroidal anti-inflammatory drugs, irrespective of the tropism to cyclooxygenase forms, alleviates manifestations of endothelial dysfunction in patients with arterial hypertension.


Asunto(s)
Aspirina/uso terapéutico , Inhibidores de la Ciclooxigenasa/uso terapéutico , Endotelio Vascular/efectos de los fármacos , Hipertensión/tratamiento farmacológico , Pirazoles/uso terapéutico , Sulfonamidas/uso terapéutico , Aspirina/farmacología , Biomarcadores/sangre , Proteína C-Reactiva/metabolismo , Celecoxib , Inhibidores de la Ciclooxigenasa/farmacología , Endotelio Vascular/diagnóstico por imagen , Endotelio Vascular/fisiopatología , Humanos , Hipertensión/sangre , Hipertensión/patología , Molécula 1 de Adhesión Intercelular/sangre , Persona de Mediana Edad , Pirazoles/farmacología , Estadísticas no Paramétricas , Sulfonamidas/farmacología , Resultado del Tratamiento , Ultrasonografía , Vasodilatación
15.
Eksp Klin Farmakol ; 71(6): 13-5, 2008.
Artículo en Ruso | MEDLINE | ID: mdl-19140508

RESUMEN

Patients with a chronic brain ischemia of stages I-II on the background of hypertension and/or cerebral atherosclerosis are characterized by energy insufficiency of the metabolism, as estimated by the activity of succinate dehydrogenase in peripheral blood lymphocytes. Within the framework of randomized comparative investigation of the efficiency of actovegin and mexidol in the complex therapy of a chronic brain ischemia, positive dynamics in reduction of the clinical semiology, restoration of cognitive processes in the brain, and reduction of the expression of subjective manifestations of the disease is established. On this background, the administration of mexidol led to restoration of the energy exchange due to substrate effects of the Krebs cycle intermediates present in its structure.


Asunto(s)
Antioxidantes/uso terapéutico , Isquemia Encefálica/tratamiento farmacológico , Metabolismo Energético/efectos de los fármacos , Hemo/análogos & derivados , Picolinas/uso terapéutico , Antioxidantes/administración & dosificación , Benciclano/administración & dosificación , Benciclano/uso terapéutico , Isquemia Encefálica/sangre , Isquemia Encefálica/metabolismo , Isquemia Encefálica/psicología , Enfermedad Crónica , Interpretación Estadística de Datos , Esquema de Medicación , Quimioterapia Combinada , Hemo/administración & dosificación , Hemo/uso terapéutico , Humanos , Linfocitos/efectos de los fármacos , Linfocitos/enzimología , Picolinas/administración & dosificación , Succinato Deshidrogenasa/metabolismo , Resultado del Tratamiento , Vasodilatadores/administración & dosificación , Vasodilatadores/uso terapéutico
16.
Eksp Klin Farmakol ; 70(3): 36-9, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-17650631

RESUMEN

The dependence of the pharmacokinetic profiles (PhP) of captopril in the phase of adaptation reactions in the organism has been studied within the framework of randomized, comparative, double cross research of bioeqivalency of captopril (Aspharma Co, Anzhero-Sudzhensk) and capoten (Bristol Myers Squibb Co.; official Russian producer, Akrikhin KhimFarmKombinat). It is established that the maximum bioaccessibility and high concentration of captopril in the blood plasma is determined on the background of physiologically optimum reactions of training and in the zone of quiet activation. These characteristics decrease during the reactions of general adaptation syndrome according to the type of increased activation and reactivation.


Asunto(s)
Adaptación Fisiológica , Inhibidores de la Enzima Convertidora de Angiotensina/farmacocinética , Antihipertensivos/farmacocinética , Captopril/farmacocinética , Síndrome de Adaptación General/metabolismo , Adulto , Disponibilidad Biológica , Femenino , Humanos , Masculino , Persona de Mediana Edad
17.
Bull Exp Biol Med ; 142(5): 583-6, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17415468

RESUMEN

Disorders in the compensatory adaptive processes underlie the development of many somatic diseases. The neuroimmunoendocrine complex and one of its main components, the hypothalamic-pituitary-adrenal system, play the leading role in the maintenance of the adaptation reserve. Treatment with a synthetic analog of hydrocortisone (final effector of this system) in low doses modulates its function by inducing positive changes in the adaptive mechanisms under conditions of stress exposure.


Asunto(s)
Dexametasona/farmacología , Estrés Fisiológico/sangre , Adaptación Fisiológica , Hormona Adrenocorticotrópica/sangre , Adulto , Ritmo Circadiano , Humanos , Hidrocortisona/sangre , Insulina/sangre , Masculino
18.
Med Tr Prom Ekol ; (11): 9-14, 2005.
Artículo en Ruso | MEDLINE | ID: mdl-16381476

RESUMEN

Possibilities of correction and prophylaxis. The authors presented results of study covering workers of radiation-dangerous plants of Siberian Chemical Enterprise, who underwent long-term exposure to outer and inner radiation in "low" doses range during the occupational activity. Target-systems for radiation effects were proved to be lipid peroxidation and antioxidant defence systems, cell energy metabolism--severity of disorders in which is correlated with degree of radiation exposure.


Asunto(s)
Homeostasis/efectos de la radiación , Enfermedades Profesionales/metabolismo , Exposición Profesional/efectos adversos , Traumatismos por Radiación/metabolismo , Radiación Ionizante , Adulto , Relación Dosis-Respuesta en la Radiación , Estudios de Seguimiento , Humanos , Peroxidación de Lípido/fisiología , Peroxidación de Lípido/efectos de la radiación , Persona de Mediana Edad , Estudios Retrospectivos
19.
Eksp Klin Farmakol ; 62(3): 37-9, 1999.
Artículo en Ruso | MEDLINE | ID: mdl-10439946

RESUMEN

Disorders in the system of blood aggregation state control (BASC) reflects the severity of OPH-gestosis (edema, proteinuria, hypertension). The duration of the therapeutic effect of the applied antithrombotics has not been studied essentially. The parameters and duration of the effective responses in the BASC system after a single dose of aspirin, curantyl, and nicotinic acid were studied in 45 females with OPH-gestosis of moderate severity. The deaggregation effect of aspirin lasted 48 h, that of nicotinic acid persisted for 7 h., the effect of curantyl developed in 72 h. and lasted 24 h. The prescription of individually selected and controlled doses of activators of fibrinolysis and deaggregants makes it possible to abolish disorders of the BASC system in pregnant females with OPH-gestosis of moderate severity.


Asunto(s)
Aspirina/administración & dosificación , Dipiridamol/administración & dosificación , Fibrinolíticos/administración & dosificación , Niacina/administración & dosificación , Inhibidores de Agregación Plaquetaria/administración & dosificación , Preeclampsia/tratamiento farmacológico , Análisis de Varianza , Femenino , Humanos , Agregación Plaquetaria/efectos de los fármacos , Preeclampsia/sangre , Embarazo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...